These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 12014728)

  • 1. Prevalence and interaction of hepatitis B and latent tuberculosis in Vietnamese immigrants to the United States.
    Patel PA; Voigt MD
    Am J Gastroenterol; 2002 May; 97(5):1198-203. PubMed ID: 12014728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactive hepatitis B surface antigen carrier state and hepatotoxicity during antituberculosis chemotherapy.
    Lee BH; Koh WJ; Choi MS; Suh GY; Chung MP; Kim H; Kwon OJ
    Chest; 2005 Apr; 127(4):1304-11. PubMed ID: 15821209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global drug-resistance patterns and the management of latent tuberculosis infection in immigrants to the United States.
    Khan K; Muennig P; Behta M; Zivin JG
    N Engl J Med; 2002 Dec; 347(23):1850-9. PubMed ID: 12466510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of hepatitis B infections in a multiracial New Zealand community.
    Milne A; Allwood GK; Moyes CD; Pearce NE; Lucas CR
    N Z Med J; 1985 Jul; 98(782):529-32. PubMed ID: 3861964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunosuppressive therapy in patients with HBeAg-positive chronic active hepatitis B?].
    Maier KP; Lepiorz H; Berthold H; Gerok W
    Leber Magen Darm; 1982 Aug; 12(4):150-3. PubMed ID: 7132529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of tuberculosis, hepatitis B virus, and intestinal parasitic infections among refugees to Minnesota.
    Lifson AR; Thai D; O'Fallon A; Mills WA; Hang K
    Public Health Rep; 2002; 117(1):69-77. PubMed ID: 12297684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
    Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
    J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
    Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
    J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers of hepatitis B infection in Tari District, Southern Highlands Province, Papua New Guinea.
    Sanders RC; Lewis D; Dyke T; Alpers MP
    P N G Med J; 1992 Sep; 35(3):197-201. PubMed ID: 1296422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B infection in Vietnamese families.
    Skinhøj P; Aldershvile J; Kjersem M; Black F
    J Med Virol; 1983; 11(2):125-9. PubMed ID: 6842191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of hepatitis B e antigen in pregnant women and patients with liver disease.
    Gill HH; Majumdar PD; Dhunjibhoy KR; Desai HG
    J Assoc Physicians India; 1995 Apr; 43(4):247-8. PubMed ID: 8713262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoniazid prophylaxis in hepatitis B carriers.
    McGlynn KA; Lustbader ED; Sharrar RG; Murphy EC; London WT
    Am Rev Respir Dis; 1986 Oct; 134(4):666-8. PubMed ID: 3767121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sero-epidemiological cross-sectional study of hepatitis B virus in Zimbabwe.
    Tswana S; Chetsanga C; Nyström L; Moyo S; Nzara M; Chieza L
    S Afr Med J; 1996 Jan; 86(1):72-5. PubMed ID: 8685787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Level of Hepatitis B Surface Antigen and Relapse After Entecavir Therapy for Chronic Hepatitis B Virus Infection.
    Chen CH; Hung CH; Hu TH; Wang JH; Lu SN; Su PF; Lee CM
    Clin Gastroenterol Hepatol; 2015 Nov; 13(11):1984-92.e1. PubMed ID: 26073492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B e antigen and the risk of hepatocellular carcinoma.
    Yang HI; Lu SN; Liaw YF; You SL; Sun CA; Wang LY; Hsiao CK; Chen PJ; Chen DS; Chen CJ;
    N Engl J Med; 2002 Jul; 347(3):168-74. PubMed ID: 12124405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of hepatitis B virus infection in children born to HBsAg positive/HBeAg positive mothers. Preliminary results of active and passive-active immunization.
    Goudeau A; Lo KJ; Coursaget P; Tong MJ; Yeh CL; Tsai YT; Lee JK; Wu TC; Yeh SH; Lee SD
    Dev Biol Stand; 1983; 54():399-404. PubMed ID: 6228473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoniazid-monoresistant tuberculosis in the United States, 1993 to 2003.
    Hoopes AJ; Kammerer JS; Harrington TA; Ijaz K; Armstrong LR
    Arch Intern Med; 2008 Oct; 168(18):1984-92. PubMed ID: 18852399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incidence of e-antigen and antibodies against it in a selected group of HBsAg-positive Vietnamese citizens].
    Michal L; Pullmann R; Szilágyiová M; Konvit I; Straka S; Skraciková J
    Cas Lek Cesk; 1991 Jan; 130(3):82-3. PubMed ID: 2004393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroepidemiology of hepatitis B infection in children in Vanuatu. Implications for vaccination strategy.
    Maher CP; Harris MS; Milne A; Johnston A; Stewart A; Waldon JA
    Med J Aust; 1991 Feb; 154(4):249-53. PubMed ID: 1994198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A predictive value of quantitative HBsAg for serum HBV DNA level among HBeAg-positive pregnant women.
    Sun KX; Li J; Zhu FC; Liu JX; Li RC; Zhai XJ; Li YP; Chang ZJ; Nie JJ; Zhuang H
    Vaccine; 2012 Aug; 30(36):5335-40. PubMed ID: 22749833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.